Catalent | CTLT - Net Income


Catalent reported $-129M in Net Income for its fiscal quarter ending in September of 2024.



Net Income Change Date
Agilent USD 434M 98M Sep/2025
AstraZeneca USD 2.33B 207M Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Bruker USD 26M 88.4M Dec/2025
Centene USD -1.1B 5.53B Dec/2025
Charles River Laboratories USD 54.42M 2.1M Sep/2025
Cigna USD 1.23B 55.22B Dec/2025
Danaher USD 1.2B 289M Dec/2025
Dentsply International USD -427M 382M Sep/2025
Elevance Health USD 547M 642M Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Glaxosmithkline GBP 2.71B 1.27B Sep/2025
Hologic USD 179.1M 8.2M Dec/2025
Humana USD -796M 991M Dec/2025
Illumina USD 334M 184M Dec/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
J&J USD 5.12B 36M Dec/2025
Laboratory Of America USD 261.1M 23.2M Sep/2025
Lonza CHF 307M 22M Dec/2024
McKesson USD 1.19B 76M Dec/2025
Merck EUR 902M 250M Sep/2025
Merck USD 2.96B 2.82B Dec/2025
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Novartis USD 3.93B 96M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Quest Diagnostics USD 245M 0 Dec/2025
Repligen USD 14.91M 44K Sep/2025
Revvity USD 98.36M 51.71M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
UnitedHealth USD 10M 2.34B Dec/2025
Waters USD 225.21M 76.29M Dec/2025
West Pharmaceutical Services USD 132.1M 7.9M Dec/2025